1. Home
  2. HQY vs RGEN Comparison

HQY vs RGEN Comparison

Compare HQY & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HealthEquity Inc.

HQY

HealthEquity Inc.

HOLD

Current Price

$84.42

Market Cap

7.9B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$161.65

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQY
RGEN
Founded
2002
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.2B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
HQY
RGEN
Price
$84.42
$161.65
Analyst Decision
Buy
Buy
Analyst Count
15
11
Target Price
$118.40
$177.18
AVG Volume (30 Days)
1.0M
571.4K
Earning Date
12-03-2025
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
99.97
N/A
EPS
2.18
0.03
Revenue
$1,290,660,000.00
$707,890,000.00
Revenue This Year
$10.35
$17.86
Revenue Next Year
$7.55
$12.44
P/E Ratio
$39.72
$6,599.47
Revenue Growth
12.20
11.74
52 Week Low
$74.07
$102.97
52 Week High
$116.65
$182.52

Technical Indicators

Market Signals
Indicator
HQY
RGEN
Relative Strength Index (RSI) 36.67 45.60
Support Level $83.40 $157.29
Resistance Level $87.41 $174.87
Average True Range (ATR) 3.58 7.07
MACD -0.49 -0.52
Stochastic Oscillator 10.14 23.05

Price Performance

Historical Comparison
HQY
RGEN

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: